Safety and Efficacy of Combination ACTHar Gel and Tacrolimus in Treatment-Resistant Focal Segmental Glomerulosclerosis and Membranous Glomerulopathy

by James Tumlin, Claude Galphin, Raul Santos, Brad Rovin
Published 2017-09-01

Phase II, randomised, double-blind, multicentre study evaluating the safety and efficacy of filgotinib and lanraplenib in patients with lupus membranous nephropathy

by Sam Lim, Matthew Baker, Vimal Derebail, Yashaar Chaichian, Mark Genovese, Panduranga Rao, Winn Chatham, Michael Bubb, Hooman Hajian, Oksana Gurtovaya, Uptal Patel, James Tumlin
Published 2020-11-01

A Phase 2, Double-Blind, Placebo-Controlled, Randomized Study of Fresolimumab in Patients With Steroid-Resistant Primary Focal Segmental Glomerulosclerosis

by Flavio Vincenti, Fernando C. Fervenza, Kirk N. Campbell, Montserrat Diaz, Loreto Gesualdo, Peter Nelson, Manuel Praga, Jai Radhakrishnan, Lorenz Sellin, Ajay Singh, Denyse Thornley-Brown, Francisco Veríssimo Veronese, Beverly Accomando, Sara Engstrand, Steven Ledbetter, Julie Lin, John Neylan, James Tumlin
Published 2017-09-01

Randomized Controlled Trial of Difelikefalin for Chronic Pruritus in Hemodialysis Patients

by Steven Fishbane, Vandana Mathur, Michael J. Germain, Shayan Shirazian, Sarbani Bhaduri, Catherine Munera, Robert H. Spencer, Frédérique Menzaghi, Michael Aaronson, Kelly Alford, Ahmed Awad, Premila Bhat, Varshab Broumand, Wesley Calhoun, Riad Darwish, Sohan Dua, Carl Dukes, Ayodele Erinle, Alexander Hadley, John Hsieh, Mohammad Kashif, Nelson Kopyt, Jayant Kumar, Jorge Kusnir, Jean Lee, Essam Maasarani, Richard Miller, M. Reza Mizani, Jesus Navarro, Amber Podoll, Thomas Pohlman, Denise Rivers, Derrick Robinson, Lisa Rich, Shayan Shirazian, Arnold Silva, Mark Smith, Joel Topf, James Tumlin, Scott Ungar, Steven Zeig
Published 2020-05-01